FDA Approves GW's Epidolex as First Plant-Derived Cannabinoid Prescription Drug

The FDA today granted GW Pharmaceuticals approval for the first drug that contains a purified drug substance derived from marijuana—the first in a new category of anti-epileptic drugs.Epidolex ® (cannabidiol) is an oral drug indicated to treat seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients two years of age or older. Epidolex is the first FDA-approved drug specifically indicated for Dravet, but among options for Lennox-Gastaut.According to GW, Epid